眼瞼基底細胞癌之長期追蹤研究

A Long-Term Follow-Up Study of Basal Cell Carcinoma of the Eyelid

眼瞼基底細胞癌是最常見之眼瞼惡性腫瘤，本文自民國69年至89年間，於台大醫院及亞東醫院，共收集79例眼瞼基底細胞癌，皆有病理切片證實，73例為原發性，6例在外院治療後復發，轉至台大接受再次治療，追蹤三年以上共有72例。男性略多於女性，平均為62.1±12.4歲；原發性腫瘤中，發生於下眼瞼為最多，病灶多小於一公分，治療方法以手術切除為主，術前正確診斷率達80.8%，自治療後至復發期間平均為45.6±39.3個月，復發率為9.1%。因此眼瞼基底細胞癌治療後，需長期追蹤，以排除復發之可能。

Basal cell carcinoma of the eyelids is the most common eyelid cancer. Between 1980 and 2000, 79 patients with histopathologically confirmed eyelid basal cell carcinoma were collected at National Taiwan University Hospital and Far Eastern Memorial Hospital in Taiwan. Seventy-three cases were primary tumors. Six cases underwent tumor excision at other hospitals and were then assigned to National Taiwan University Hospital for treatment of the recurrences. The follow up study more than 3 years was undertaken for 72 patients. Males were slightly more than females. The mean age at diagnosis was 62.1±12.4 years. In primary basal cell carcinoma of the eyelids, tumors developed most commonly on the lower eyelid. Most of the lesions were found within 1 cm. The most common treatment modality was surgical excision. The rate of accurate diagnosis was 80.8%. The mean interval to recurrence was 45.6±39.3 months. The recurrence rate of 9.1% was noted. In summary, the long-term follow up is needed after treatment of eyelid basal cell carcinoma.